COVID-19 patients at high risk of hospitalisation or those with severe disease should be given a combination of two antibody treatments, according to the latest World Health Organization guidelines published in The BMJ on Friday. The WHO Guideline Development Group (GDG) panel recommends treatment combining casirivimab and imdevimab for two specific groups of patients with COVID-19.from IndiaTV India: Google News Feed https://ift.tt/3ohVaRJ
via
No comments:
Post a Comment
Please do not enter spam link in the comment box. Suggestions are invited for improvement.